INTEGRATED BIOPHARMA, INC. (INBP) Shareholders’ equity 2018–2026
INTEGRATED BIOPHARMA, INC. (INBP) shareholders’ equity at each fiscal year-end, per SEC filings.
$17.7MFY2026 · since FY2018: -$5.2M → $17.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $17.7M | -13.0% |
| FY2025 | $20.3M | +5.6% |
| FY2024 | $19.2M | +2.0% |
| FY2023 | $18.9M | +1.5% |
| FY2022 | $18.6M | +29.6% |
| FY2021 | $14.3M | +136.3% |
| FY2020 | $6.1M | +220.5% |
| FY2019 | $1.9M | +136.2% |
| FY2018 | -$5.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice